BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 7, 2011
View Archived Issues
PCI-27483/gemcitabine combination is safe in advanced/metastatic pancreatic cancer
Read More
French scientists describe novel piperidine derivatives
Read More
Cancer-targeting nanoparticle-size Cornell dots to enter first-in-human trial
Read More
Bharat Biotech initiates phase III trial of thrombolytic agent THR-100 in India
Read More
Bryostatin 1 prevents synapse loss in vivo, improving symptoms of AD
Read More
Preclinical findings support role of N-acetylcysteine in TTP therapy
Read More
Armed oncolytic virus OBP-702 active against osteosarcoma cells
Read More
New drug discovery strategy creates synthetic analogues based on natural products
Read More
Derma Sciences reports phase II data on DSC-127 in diabetes-related foot ulcers
Read More
Kythera Biopharma reports phase IIb data on ATX-101
Read More
Galapagos and Merck & Co. agree to end strategic alliances
Read More
CardioVascular BioTherapeutics files for FDA fast track status for CVBT-141B
Read More
Tacere Therapeutics achieves milestone under collaboration with Pfizer
Read More
FDA sets new PDUFA date for AstraZeneca's Brilinta
Read More
Ceregene advances phase IIb CERE-120 trial in Parkinson's disease
Read More
Natural marine product largazole has osteogenic potential
Read More
Paclitaxel shows promise as treatment of spinal cord injury
Read More
FluEnz approved in E.U. for prevention of seasonal flu in children
Read More
SHELTER trial data reported on resminostat in sorafenib-resistant hepatocellular carcinoma
Read More
Lilly and JDRF to study beta-cell regeneration to treat type 1 diabetes
Read More
Anacor Pharma begins phase IIb trial of AN-2728 in psoriasis
Read More
AstraZeneca discontinues ENTHUSE Study 15 of zibotentan in prostate cancer
Read More
Aveo's anticancer antibody AV-299 to be called ficlatuzumab
Read More
Phase IIb trial of EpiCept NP-1 in chemotherapy-induced peripheral neuropathy meets primary endpoint
Read More
FDA removes clinical hold on Icagen's IND for epilepsy candidate ICA-10566
Read More